Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BRD4 | O60885 | 2/20 | 0.44 |
| ▸ | HDAC6 | Q9UBN7 | 6/20 | 0.42 |
| ▸ | HDAC3 | O15379 | 3/20 | 0.42 |
| ▸ | HDAC7 | Q8WUI4 | 1/20 | 0.42 |
| ▸ | HDAC9 | Q9UKV0 | 1/20 | 0.42 |
| ▸ | HDAC1 | Q13547 | 2/20 | 0.41 |
| ▸ | HDAC2 | Q92769 | 2/20 | 0.41 |
| ▸ | HDAC8 | Q9BY41 | 2/20 | 0.41 |
| ▸ | RAB9A | P51151 | 1/20 | 0.41 |
| ▸ | CHEK2 | O96017 | 4/20 | 0.40 |
| ▸ | NPBWR1 | P48145 | 1/20 | 0.40 |
| ▸ | MAPT | P10636 | 1/20 | 0.39 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.39 |
| ▸ | DGAT1 | O75907 | 1/20 | 0.39 |
| ▸ | KLKB1 | P03952 | 1/20 | 0.38 |
| ▸ | F7 | P08709 | 1/20 | 0.38 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.38 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.38 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25049504 | 0.89 | HDAC6 (0.40) | BRD4HDAC6HDAC3HDAC7HDAC9 | |
| SCHEMBL12582121 | 0.88 | HDAC6 (0.44) | BRD4HDAC6HDAC3HDAC7HDAC9 | |
| SCHEMBL23682677 | 0.85 | HDAC6 (0.42) | BRD4HDAC6HDAC3HDAC7HDAC9 | |
| SCHEMBL23744819 | 0.83 | HDAC6 (0.47) | BRD4HDAC6HDAC3HDAC7HDAC9 | |
| SCHEMBL24630423 | 0.81 | CHEK2 (0.46) | BRD4HDAC6HDAC3HDAC7HDAC9 | |
| SCHEMBL23815596 | 0.81 | BRD4 (0.43) | BRD4HDAC6HDAC3HDAC7HDAC9 | |
| SCHEMBL23815729 | 0.79 | HDAC6 (0.40) | BRD4HDAC6HDAC3HDAC7HDAC9 | |
| SCHEMBL23682745 | 0.77 | HDAC6 (0.42) | BRD4HDAC6HDAC3HDAC7HDAC9 | |
| SCHEMBL23682616 | 0.76 | HDAC6 (0.41) | BRD4HDAC6HDAC3HDAC7HDAC9 | |
| SCHEMBL23745079 | 0.74 | CHEK2 (0.47) | BRD4HDAC6HDAC3HDAC7HDAC9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210284629-A1 | METHODS AND COMPOUNDS FOR THE TREATMENT OF GENETIC DISEASE | Design Therapeutics, Inc. | 2021-09-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210284629-A1 | METHODS AND COMPOUNDS FOR THE TREATMENT OF GENETIC DISEASE | NEDD4, UBQLN2, UBTF | BRD4 392/4885HDAC6 357/4885HDAC3 1673/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.